Teladoc Health (TDOC) Enterprise Value (2014 - 2026)

Teladoc Health (TDOC) has 13 years of Enterprise Value data on file, last reported at -$750.7 million in Q1 2026.

• For the quarter ending Q1 2026, Enterprise Value rose 37.09% year-over-year to -$750.7 million; the trailing twelve-month figure through Mar 2026 stood at -$750.7 million (up 37.09% YoY), and the FY2025 full-year result was -$781.1 million, up 39.84% from the prior year.
• Enterprise Value grew to -$750.7 million in Q1 2026, from -$781.1 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$679.6 million in Q2 2025 to a low of -$1.3 billion in Q4 2024.
• A 5-year average of -$969.1 million and a median of -$918.2 million in 2022 frame the typical range for Enterprise Value.
• Across the five-year window, Enterprise Value fell 23.56% in 2024 and jumped 41.61% in 2025, its largest moves.
• Tracing TDOC's Enterprise Value over 5 years: stood at -$918.2 million in 2022, then decreased by 22.38% to -$1.1 billion in 2023, then fell by 15.54% to -$1.3 billion in 2024, then jumped by 39.84% to -$781.1 million in 2025, then grew by 3.89% to -$750.7 million in 2026.
• Business Quant data shows TDOC's Enterprise Value at -$750.7 million in Q1 2026, -$781.1 million in Q4 2025, and -$726.2 million in Q3 2025.